NSEAnalysts/Institutional Investor Meet/Con. Call Updates2d ago · 18 Aug 2026, 05:13 pm
Analysts/Institutional Investor Meet/Con. Call Updates
India Pesticides Limited · IPL
✦ AI SummaryResults
India Pesticides Limited has informed the Exchange about Transcript of Earning call for Q1 FY27. The company's consolidated revenue from operations was at INR 256 crores compared to INR 282 crores in Q1 FY26. EBITDA for the quarter was at INR 39 crores with an EBITDA margin of 15.4% while PAT was at INR 23 crores.
Analysis Scores
Earnings Impact6/10
Growth Catalyst4/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk3/10
Liquidity Impact7/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
India Pesticides Limited has informed the Exchange about Transcript of Earning call for Q1 FY27
Attachments (1)
📄pdf
Download →
IPL_18082026171306_Transcript_of_the_Earnings_Call.pdf
View document text
INDIA PESTICIDES LIMITED
An ISO 9001:2015, 14001:2015, 45001:2018 and 10002:2018 Company
CIN No. L24112 UP1984PLC006894
GSTIN- 09AAACI3591D1ZO
IPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIIPLIPLIPLLIPLIPL
IPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIIPLIPLIPLIPLIPLIPLIPLIPL
Water Works Road, Aishbagh, Lucknow – 226004 (INDIA)
Tel: +91-522-2653602, 2653603, 2653622, 4041014
Fax: +91-522-2653610
Website: www.indiapesticideslimited.com
E-mail: info@indiapesticideslimited.com
Date: 18.08.2026
To To
The Manager, The Manager,
Listing Department Listing & Compliance Department
BSE Limited National Stock Exchange of India Ltd.
P. J. Towers, Dalal Street, Mumbai-400001 Exchange Plaza, Plot no. C/1, G Block,
Scrip Code: 543311
Bandra- Kurla Complex, Mumbai-400051
ISIN: INE0D6701023
Symbol: IPL
Dear Sir/ Ma'am,
Sub: Transcript of the Earnings Call for the quarter ended 30th June, 2026.
Pursuant to Regulation 30(6) read with Part A of Schedule III of the SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015, we hereby enclose the transcript of the Analyst/Investors Call
held on Thursday, 13th August, 2026 at 12:30 P.M, in respect of the Un-audited Standalone and Consolidated
Financial Results of the Company for the quarter ended 30th June, 2026.
The transcript of the earnings call is also available on the Company’s website at
www.indiapesticideslimited.com
Kindly take the above on your record.
Thanking you
Yours faithfully,
For India Pesticides Limited
(Narendra Ojha)
Company Secretary and Compliance Officer
Encl.: As Above
IPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIIPLIPLIPLIPL
Regd. Office: Swarup Bhawan, 35-A, Civil Lines, Bareilly – 243 001. Uttar Pradesh, India. Phone: 0581-2567476
Manufacturing Unit 1: Plot No: E-17 to E-23 & G-31 to G-35, UPSIDC Industrial Area, Dewa Road, Chinhat, Lucknow, (UP)
Manufacturing Unit 2: Plot No: K-2 to K-12 & D-2 to D-4, UPSIDC Industrial Area, Sandila, Hardoi, (UP)
“India Pesticides Limited
Q1 FY27 Earnings Conference Call”
August 13, 2026
MANAGEMENT: MR. D. K. JAIN – CHIEF EXECUTIVE OFFICER
MR. S. P. GUPTA – CHIEF FINANCIAL OFFICER
MODERATOR: MR. NITIN RAHEJA – DOLAT CAPITAL
Page 1 of 12
India Pesticides Limited
August 13, 2026
Moderator: Ladies and gentlemen, good day and welcome to the India Pesticides Q1 FY27 Earnings
Conference Call hosted by Dolat Capital. As a reminder, all participant lines will be in the listen-
only mode and there will be an opportunity for you to ask questions after the presentation
concludes. Should you need assistance during the conference call, please signal an operator by
pressing star then zero on your touchtone phone. Please note that this call is being recorded.
I now hand the conference over to Mr. Nitin Raheja from Dolat Capital. Thank you and over to
you, sir.
Nitin Raheja: Thank you, Shruti. Good afternoon, everyone. On behalf of Dolat Capital, I would like to thank
the management of India Pesticides Limited for giving us the opportunity to host their Q1 FY27
earnings conference call. From the management team, we have with us Mr. D.K. Jain, Chief
Executive Officer, and Mr. S.P. Gupta, Chief Financial Officer.
Without further ado, I would like to hand over the call to the management for their opening
remarks, post which we will open the forum for the Q&A session. Thank you and over to you,
sir.
D. K. Jain: Thank you, Nitin ji. Good afternoon, ladies and gentlemen. I take pleasure in welcoming you all
to the Q1 FY27 earnings conference of India Pesticides Limited. I hope you and your family are
doing well. I take the pleasure of welcoming you all to this conference and I trust you have
reviewed the financial statements and earning presentation uploaded on the exchanges and our
website.
We commenced FY27 amid a challenging operating environment in the international and
domestic agrochemical market. During the quarter, the industry continued to experience subdued
demand conditions, particularly in paddy and other crop protection segments. Despite these near-
term challenges, IPL remained focused on operational discipline, customer engagement and
maintaining efficiency across its manufacturing operations.
During FY27 Q1, consolidated revenue from operations was at INR 256 crores compared to INR
282 crores in Q1 FY26. EBITDA for the quarter was at INR39 crores with an EBITDA margin
of 15.4% while PAT was at INR 23 crores. The performance during the quarter was impacted
by softer domestic demand for the company's key herbicide namely Pretilachlor along with the
higher employee and fuel cost. However, the company continued to focus on cost management,
improving operational efficiencies and disciplined execution across business segments.
From a business perspective, domestic market remains impacted during the quarter due to a
slower demand condition, deficient rainfall resulting in nonsowing or slow sowing during this
period. Export revenue during FY27 quarter 1 was at INR 89 crores contributing approximately
35% of total revenue.
The company continues to strengthen its presence across more than 35 countries and maintains
long-standing relationship with global agrochemical companies. Our ability to manufacture
complex offpatent technicals supported by strong quality standards and regulatory compliance
continues to support our position as a preferred partner for global customers.
Page 2 of 12
India Pesticides Limited
August 13, 2026
A key milestone during the quarter was the receipt of Technical Equivalence approval from the
European Union for one of our fungicide products. This approval represents an important step
in our global expansion strategy and strengthens our ability to cater to international markets.
It enhances our access to the European market and creates opportunities for expanding our export
business over the coming years. This achievement reflects the strength of our R&D capabilities,
product development expertise and continued effort, focus on meeting global requirements of
regulatory point of view.
Our manufacturing capabilities continue to remain an important pillar of our growth strategy.
The company currently operates manufacturing facilities at Sandila, Hardoi, Dewa Road and
with a combined capacity of 28,300 metric tons of technical and about 10,200 metric tons of
formulated products.
Development at our Hamirpur facility continues to progress as planned with 2 out of 10 blocks
currently operational. The facility provides a clear pathway for future capacity expansion and
will support incremental growth opportunities across specialty products.
During the quarter, we continued to strengthen our backward integration initiatives and
manufacturing capabilities. Our intermediate plant developed using in-house indigenous R&D
technology, supports supply chain stability and reduces dependence on imported intermediates.
These initiatives are aligned with our focus on developing self-reliant manufacturing capabilities
and improving operational efficiency over the long run.
Research and development continue to be the key focus area for IPL. Our DSIR approved R&D
facilities remain focused on process innovation, development of new molecules and
intermediates, improving product yield
[Showing first 8,000 characters — download PDF for full document]